• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Whole grain consumption associated with decreased all-cause, cardiovascular mortality

byAnees DaudandJames Jiang
January 7, 2015
in Cardiology, Chronic Disease, Oncology, Public Health
Reading Time: 3 mins read
Whole grain consumption associated with decreased all-cause, cardiovascular mortality
Share on FacebookShare on Twitter

1. Based on the results of two prospective cohort studies in the US, the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS), increasing whole grain consumption was associated with lower all-cause mortality and cardiovascular disease (CVD) mortality, but not cancer-related mortality.

2. Furthermore, each additional serving of whole grain was associated with 5-10% reduced all-cause and CVD mortality.

Evidence Rating Level: 2 (Good)       

Study Rundown: Whole grains have been linked to favorable health outcomes based on a variety of different mechanisms, including better glucose and lipid metabolism, anti-inflammatory effects, etc. However, the effect of whole grain consumption on overall mortality has not been rigorously studied. This study, which included data from two large, prospective cohort studies, was conducted to determine the overall and cause-specific mortality effects from whole grain consumption. Based on the results of this study, increasing whole grain consumption was associated with lower all-cause mortality and cardiovascular disease (CVD) mortality, but not cancer-related mortality. Furthermore, each additional serving of whole grain was associated with 5-10% reduced all-cause and CVD mortality.

The strength of this study was the fact that the investigators examined the results of two similarly focused studies, which increases the generalizability. However, the measured variables, especially the types of foods considered ‘whole grains,’ were somewhat different between the two studies evaluated. In addition, the self-reporting methodology introduced bias. Additionally, while the long follow-up periods were helpful in determining mortality benefits, the trends of foods and food labeling have changed in that period of time, which may have also introduced bias in the study.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

2 Minute Medicine Rewind June 29, 2026

Relevant Reading: Whole-grain, cereal fiber, bran, and germ intake and the risks of all-cause and cardiovascular disease-specific mortality among women with type 2 diabetes mellitus.

In-Depth [prospective cohort study]: This study combined the results of two prospective cohort trials, the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS). The food intake log was derived from self-reported food frequency questionnaires (FFQs), which have been validated for use in these kinds of studies. Other health history was collected at baseline, next-of-kin were used to determine time of death, and medical records used to determine the cause of death. There were 24 years of follow-up in the NHS and 26 years in the HPFS, resulting in a total of 2,727,006 person-years of follow-up.

The pooled hazard ratios for high amounts of whole grain consumption suggested decreased all-cause mortality (HR 0.91; 95%CI 0.88-0.95; P for trend <0.001) and CVD mortality (HR 0.85; 95%CI 0.78-0.92; P for trend <0.001). The results for cancer-related mortality were not statistically significant. In addition, the investigators estimated that increasing an additional serving of whole grain (defined as 28 g/day) lowered all-cause mortality by 5% (95%CI 2-7%) and CVD mortality by 9% (95%CI 4-13%).

More from this author: Cardiac mortality paradoxically lower during times of national cardiology conferences, Active smoking cessation intervention may provide tangible results [Project CLIQ], Reperfusion therapy may be suboptimal for STEMIs requiring transfers, Statin therapy does not prevent osteoporotic fractures [JUPITER trial], Basic life support associated with greater survival in cardiac arrest

Image: PD

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: cardiovascular diseasediet
Previous Post

Criminal behavior more associated with frontotemporal dementia than Alzheimer disease

Next Post

Standardized measures effectively tracked psoriasis and acne outcomes

RelatedReports

Behavioral dysregulation in infancy predicts later child mental health
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Collage of medical tech icons circling a central chip with 'AI Roundup' title and 2 Minute Medicine logo in teal background.
AI Roundup

2MM: AI Roundup: NHS England expands Microsoft Copilot nationwide, ARPA-H advances autonomous cardiovascular AI, FDA advisors back Moderna’s mRNA influenza vaccine, and UpDoc earns first clearance for a patient-facing large language model

September 3, 2026
Weekly Rewinds

2 Minute Medicine Rewind June 29, 2026

June 29, 2026
Jessica Lau
Psychiatry

WHO launches 2026 global initiative to bridge the schizophrenia mortality gap

September 4, 2026
Next Post
Standardized measures effectively tracked psoriasis and acne outcomes

Standardized measures effectively tracked psoriasis and acne outcomes

Classics Series, Landmark Trials in Medicine

The AMPLIFY trial: Apixaban for treatment of venous thromboembolism [Classics Series]

Use of injectable contraceptive, Depo-Provera, linked to increased risk of HIV

Use of injectable contraceptive, Depo-Provera, linked to increased risk of HIV

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
  • Artificial intelligence (AI) chatbot reduced depression, anxiety, and eating disorder risk symptoms
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.